Stockscreener 앱 받기
46.82
0.30%
0.14
전일 마감가:
$46.68
열려 있는:
$46.51
하루 거래량:
7.93M
Relative Volume:
1.35
시가총액:
$91.72B
수익:
$8.79B
순이익/손실:
$2.03B
주가수익비율:
22.72
EPS:
2.0606
순현금흐름:
$2.05B
1주 성능:
-48.19%
1개월 성능:
-52.23%
6개월 성능:
-42.54%
1년 성능:
-27.07%
1일 변동 폭
$46.17
$46.94
1주일 범위
$45.05
$92.85
52주 변동 폭
$45.05
$100.34
몬스터 베버리지 Stock (MNST) Company Profile
명칭
Monster Beverage Corp
전화
909-739-6200
주소
1 MONSTER WAY, CORONA, CA
Compare MNST vs KO, PEP, KOF, COKE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
46.82 | 90.08B | 8.79B | 2.03B | 2.05B | 2.0606 |
KO
Coca Cola Co
|
87.71 | 373.07B | 49.82B | 13.77B | 12.56B | 3.1761 |
PEP
Pepsico Inc
|
140.79 | 189.31B | 96.91B | 10.52B | 9.28B | 7.6247 |
KOF
Coca Cola Femsa Sab De Cv Adr
|
108.94 | 23.08B | 15.88B | 1.31B | 727.67M | 5.9296 |
COKE
Coca Cola Consolidated Inc
|
189.11 | 12.57B | 7.49B | 578.53M | 665.12M | 6.8502 |
몬스터 베버리지 Stock (MNST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-23 | 재확인 | Stifel | Buy |
| 2026-04-20 | 재확인 | TD Cowen | Hold |
| 2026-04-10 | 재확인 | BofA Securities | Buy |
| 2026-04-08 | 재확인 | Wells Fargo | Overweight |
| 2026-04-07 | 재확인 | UBS | Neutral |
| 2026-03-16 | 재확인 | Wells Fargo | Overweight |
| 2026-03-03 | 재확인 | Argus | Buy |
| 2026-02-27 | 재확인 | Citigroup | Buy |
| 2026-02-27 | 재확인 | Deutsche Bank | Buy |
| 2026-02-27 | 재확인 | Evercore ISI | Outperform |
| 2026-02-27 | 재확인 | JP Morgan | Neutral |
| 2026-02-27 | 재확인 | Jefferies | Buy |
| 2026-02-27 | 재확인 | Piper Sandler | Overweight |
| 2026-02-27 | 재확인 | Stifel | Buy |
| 2026-02-27 | 재확인 | TD Cowen | Hold |
| 2026-02-27 | 재확인 | UBS | Neutral |
| 2026-02-27 | 재확인 | Wells Fargo | Overweight |
| 2026-02-24 | 재확인 | RBC Capital Mkts | Outperform |
| 2026-02-23 | 재확인 | Evercore ISI | Outperform |
| 2026-02-20 | 재확인 | Deutsche Bank | Buy |
| 2026-01-27 | 재확인 | Argus | Buy |
| 2026-01-26 | 재확인 | Morgan Stanley | Overweight |
| 2026-01-16 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2026-01-14 | 재확인 | Citigroup | Buy |
| 2026-01-14 | 재확인 | UBS | Neutral |
| 2026-01-08 | 재확인 | TD Cowen | Hold |
| 2026-01-05 | 재확인 | Wells Fargo | Overweight |
| 2025-12-19 | 재확인 | BofA Securities | Buy |
| 2025-12-03 | 재확인 | BMO Capital Markets | Market Perform |
| 2025-12-03 | 재확인 | Goldman | Buy |
| 2025-12-03 | 재확인 | Piper Sandler | Overweight |
| 2025-12-03 | 재확인 | Wells Fargo | Overweight |
| 2025-12-01 | 재확인 | Piper Sandler | Overweight |
| 2025-12-01 | 재확인 | RBC Capital Mkts | Outperform |
| 2025-11-07 | 재확인 | BofA Securities | Buy |
| 2025-11-07 | 재확인 | Deutsche Bank | Buy |
| 2025-11-07 | 재확인 | Evercore ISI | Outperform |
| 2025-11-07 | 재확인 | Goldman | Buy |
| 2025-11-07 | 재확인 | JP Morgan | Neutral |
| 2025-11-07 | 재확인 | Morgan Stanley | Overweight |
| 2025-11-07 | 재확인 | Piper Sandler | Overweight |
| 2025-11-07 | 재확인 | UBS | Neutral |
| 2025-11-07 | 재확인 | Wells Fargo | Overweight |
| 2025-10-30 | 재확인 | Deutsche Bank | Buy |
| 2025-10-24 | 재확인 | JP Morgan | Neutral |
| 2025-10-24 | 재확인 | Stifel | Buy |
| 2025-10-10 | 재확인 | RBC Capital Mkts | Outperform |
| 2025-10-08 | 재확인 | UBS | Neutral |
| 2025-09-16 | 재확인 | Citigroup | Buy |
| 2025-08-13 | 재확인 | Roth Capital | Neutral |
| 2025-08-08 | 재확인 | JP Morgan | Neutral |
| 2025-08-08 | 재확인 | Morgan Stanley | Overweight |
| 2025-08-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2025-08-08 | 재확인 | UBS | Neutral |
| 2025-08-08 | 재확인 | Wells Fargo | Overweight |
| 2025-07-17 | 재확인 | UBS | Neutral |
| 2025-07-09 | 다운그레이드 | Rothschild & Co Redburn | Buy → Neutral |
| 2025-06-13 | 재확인 | Goldman | Buy |
| 2025-06-13 | 재확인 | Wells Fargo | Overweight |
| 2025-06-12 | 재확인 | Morgan Stanley | Overweight |
| 2025-06-12 | 재개 | Stifel | Buy |
| 2025-05-14 | 재확인 | Roth Capital | Neutral |
| 2025-05-09 | 재확인 | JP Morgan | Neutral |
| 2025-05-09 | 재확인 | Morgan Stanley | Overweight |
| 2025-05-09 | 재확인 | Piper Sandler | Neutral |
| 2025-05-09 | 재확인 | TD Cowen | Hold |
| 2025-05-09 | 재확인 | UBS | Neutral |
| 2025-05-05 | 재확인 | Wells Fargo | Overweight |
| 2025-05-02 | 재확인 | JP Morgan | Neutral |
| 2025-04-25 | 재확인 | BofA Securities | Buy |
| 2025-04-23 | 재확인 | Truist | Sell |
| 2025-04-17 | 재확인 | UBS | Neutral |
| 2025-04-16 | 재확인 | Jefferies | Buy |
| 2025-04-14 | 재확인 | Citigroup | Buy |
| 2025-04-02 | 재확인 | Wells Fargo | Overweight |
| 2025-03-03 | 재확인 | UBS | Neutral |
| 2025-02-28 | 재확인 | Citigroup | Buy |
| 2025-02-28 | 재확인 | Deutsche Bank | Buy |
| 2025-02-28 | 재확인 | JP Morgan | Neutral |
| 2025-02-28 | 재확인 | Morgan Stanley | Overweight |
| 2024-12-19 | 재확인 | Exane BNP Paribas | Underperform |
| 2024-12-06 | 개시 | Needham | Hold |
| 2024-11-12 | 재확인 | Argus | Buy |
| 2024-11-11 | 재확인 | TD Cowen | Hold |
| 2024-11-08 | 재확인 | Deutsche Bank | Buy |
| 2024-11-08 | 재확인 | JP Morgan | Neutral |
| 2024-11-08 | 재확인 | Stifel | Buy |
| 2024-11-08 | 재확인 | UBS | Neutral |
| 2024-11-05 | 재확인 | Wells Fargo | Overweight |
| 2024-11-04 | 재확인 | JP Morgan | Neutral |
| 2024-10-15 | 재확인 | BofA Securities | Buy |
| 2024-10-07 | 재확인 | UBS | Neutral |
| 2024-08-12 | 재확인 | ROTH MKM | Neutral |
| 2024-08-09 | 재확인 | Truist | Sell |
| 2024-08-08 | 재확인 | Citigroup | Buy |
| 2024-08-08 | 재확인 | Deutsche Bank | Buy |
| 2024-08-08 | 재확인 | JP Morgan | Neutral |
| 2024-08-08 | 재확인 | Jefferies | Buy |
| 2024-08-08 | 재확인 | Piper Sandler | Neutral |
| 2024-08-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2024-08-08 | 재확인 | UBS | Neutral |
| 2024-08-08 | 재확인 | Wells Fargo | Overweight |
| 2024-07-23 | 재확인 | JP Morgan | Neutral |
| 2024-07-15 | 재확인 | TD Cowen | Hold |
| 2024-07-10 | 재확인 | BofA Securities | Buy |
| 2024-07-10 | 재확인 | Citigroup | Buy |
| 2024-06-25 | 재확인 | Wells Fargo | Overweight |
| 2024-06-24 | 개시 | Exane BNP Paribas | Underperform |
| 2024-06-17 | 재확인 | Stifel | Buy |
| 2024-05-03 | 재확인 | Morgan Stanley | Overweight |
| 2024-05-03 | 재확인 | Piper Sandler | Neutral |
| 2024-05-03 | 재확인 | UBS | Neutral |
| 2024-01-17 | 재확인 | BMO Capital Markets | Market Perform |
| 2024-01-17 | 재확인 | Citigroup | Buy |
| 2024-01-17 | 재확인 | Goldman | Buy |
| 2024-01-17 | 재확인 | JP Morgan | Overweight |
| 2023-11-20 | 재확인 | Piper Sandler | Neutral |
| 2023-11-20 | 재확인 | ROTH MKM | Neutral |
| 2023-11-13 | 개시 | Jefferies | Buy |
| 2023-11-03 | 재확인 | Wells Fargo | Overweight |
| 2023-10-31 | 재확인 | JP Morgan | Overweight |
| 2023-10-24 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-10-23 | 재확인 | Deutsche Bank | Buy |
| 2023-10-05 | 업그레이드 | CFRA | Hold → Buy |
| 2023-08-14 | 개시 | HSBC Securities | Buy |
| 2023-08-10 | 재확인 | ROTH MKM | Neutral |
| 2023-08-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | 재확인 | UBS | Neutral |
| 2023-07-31 | 재확인 | Stifel | Buy |
| 2023-07-25 | 재확인 | Evercore ISI | Outperform |
| 2023-06-08 | 개시 | Piper Sandler | Neutral |
| 2023-05-08 | 재확인 | BMO Capital Markets | Market Perform |
| 2023-05-08 | 재확인 | ROTH MKM | Neutral |
| 2023-05-05 | 재확인 | BofA Securities | Buy |
| 2023-05-05 | 재확인 | Citigroup | Buy |
| 2023-05-05 | 재확인 | Deutsche Bank | Buy |
| 2023-05-05 | 재확인 | Goldman | Buy |
| 2023-05-05 | 재확인 | JP Morgan | Overweight |
| 2023-05-05 | 재확인 | Morgan Stanley | Overweight |
| 2023-05-05 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-05-05 | 재확인 | Truist | Buy |
| 2023-05-05 | 재확인 | UBS | Neutral |
| 2023-05-05 | 재확인 | Wells Fargo | Overweight |
| 2023-04-06 | 재확인 | UBS | Neutral |
| 2023-04-06 | 재확인 | Wedbush | Neutral |
| 2023-03-06 | 업그레이드 | Redburn | Neutral → Buy |
| 2023-03-01 | 재확인 | BMO Capital Markets | Market Perform |
| 2023-03-01 | 다운그레이드 | CFRA | Buy → Hold |
| 2023-03-01 | 재확인 | Citigroup | Buy |
| 2023-03-01 | 재확인 | JP Morgan | Overweight |
| 2023-03-01 | 재확인 | Morgan Stanley | Overweight |
| 2023-03-01 | 재확인 | Truist | Buy |
| 2023-03-01 | 재확인 | Wells Fargo | Overweight |
| 2023-02-17 | 개시 | Citigroup | Buy |
| 2023-01-18 | 재확인 | BMO Capital Markets | Market Perform |
| 2023-01-18 | 재확인 | Evercore ISI | Outperform |
| 2022-11-04 | 재확인 | BofA Securities | Buy |
| 2022-11-04 | 재확인 | Morgan Stanley | Overweight |
| 2022-11-04 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-11-04 | 재확인 | UBS | Neutral |
| 2022-11-04 | 재확인 | Wells Fargo | Overweight |
| 2022-11-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-11 | 개시 | Wedbush | Neutral |
| 2022-08-05 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-07-05 | 개시 | ROTH Capital | Neutral |
| 2022-06-06 | 재확인 | Morgan Stanley | Overweight |
| 2022-05-18 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-02-25 | 재확인 | Citigroup | Buy |
| 2022-02-25 | 재확인 | Cowen | Market Perform |
| 2022-02-25 | 재확인 | Deutsche Bank | Buy |
| 2022-02-25 | 재확인 | Guggenheim | Buy |
| 2022-02-25 | 재확인 | JP Morgan | Neutral |
| 2022-02-17 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 개시 | Redburn | Neutral |
| 2021-10-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-07-23 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-05-07 | 재확인 | Truist | Buy |
| 2021-02-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-01-20 | 개시 | Bernstein | Mkt Perform |
| 2021-01-15 | 재확인 | Citigroup | Neutral |
| 2021-01-15 | 재확인 | Deutsche Bank | Buy |
| 2021-01-15 | 재확인 | Truist | Buy |
| 2020-12-10 | 재확인 | Morgan Stanley | Overweight |
| 2020-12-08 | 개시 | Wells Fargo | Overweight |
| 2020-11-17 | 업그레이드 | UBS | Sell → Neutral |
| 2020-11-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-20 | 재확인 | Guggenheim | Buy |
| 2020-05-28 | 재확인 | Stifel | Buy |
| 2020-05-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-05-05 | 재확인 | Guggenheim | Buy |
| 2020-04-16 | 재개 | BofA/Merrill | Buy |
| 2020-04-01 | 재개 | Goldman | Buy |
| 2020-03-20 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-03-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-10-17 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2019-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-08 | 재확인 | BMO Capital Markets | Market Perform |
| 2019-08-08 | 재확인 | Morgan Stanley | Equal-Weight |
| 2019-08-08 | 재확인 | UBS | Sell |
| 2019-04-01 | 다운그레이드 | Macquarie | Outperform → Neutral |
| 2019-03-28 | 재확인 | Morgan Stanley | Equal-Weight |
모두보기
몬스터 베버리지 주식(MNST)의 최신 뉴스
$1000 Invested In Monster Beverage 15 Years Ago Would Be Worth This Much Today - Benzinga
Monster Beverage (NASDAQ:MNST): Strong Growth Meets a Promising Technical Setup - ChartMill
Monster Beverage Corp. stock outperforms competitors on strong trading day - MarketWatch
Monster Beverage stock steadies after Q2 earnings beat as margin questions linger - ad-hoc-news.de
Monster’s energy drinks surge as alcohol sales fall 15% - The Drinks Business
Monster Beverage (MNST) Stock Looks Near Fair Value While Earnings Price In More - simplywall.st
Monster Beverage Corporation (MNST) Stock Forecasts - Yahoo Finance
Monster Beverage achieves monster results - Food Business News
Rep. Josh Gottheimer Purchases Shares of Monster Beverage Corporation (NASDAQ:MNST) - MarketBeat
Will Strong Q2 2026 International-Driven Results Change Monster Beverage's (MNST) Margin and Growth Narrative? - Yahoo Finance
Monster Beverage Stock Split: Why MNST Shares Double, Not Value on August 11 - EBC Financial Group
Is iShares US Consumer Staples ETF a Better Buy Than Invesco Food & Beverage? - The Motley Fool
Fund Update: 153,098 MONSTER BEVERAGE (MNST) shares added to Vanguard Personalized Indexing Management, LLC portfolio - quiverquant.com
Monster Beverage Corp Stock (MNST) Moved Down by 49.76% on Aug 11: Key Drivers Unveiled - tradingkey.com
Why is Monster Beverage stock climbing today? By Investing.com - Investing.com UK
MNST Q2 Deep Dive: International Acceleration, Margin Compression, and Innovation Drive Focus - Yahoo Finance
Monster Beverage Rallies on Split, Earnings, Upgrades - TradingPedia
Why is Monster Beverage stock climbing today? - Investing.com
MNST Looks 16.0% Overvalued on GF Value™ as Market Reacts to Q2 EPS - GuruFocus
Monster Beverage stock hits 52-week low at $45.72 By Investing.com - Investing.com UK
Monster Beverage stock hits 52-week low at $45.72 - Investing.com
Why Monster Beverage (MNST) Is Back In The Spotlight - simplywall.st
Is Monster Beverage’s Best-Case Scenario Already Priced Into the Stock? - MarketBeat
Investing in Monster Beverage (MNST)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Monster Beverage (NASDAQ:MNST) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
stock market monster |fundamental engine + market mechanism| for OANDA:XAUUSD by currencynerd - TradingView
MNST Maintained by RBC Capital -- Price Target Raised to $100 - GuruFocus
Monster Beverage Corp (MNST) Shares Fall 4.0% -- GF Value Says S - GuruFocus
Monster Beverage Corp. stock underperforms Friday when compared to competitors - MarketWatch
MNST Maintained by Piper Sandler -- Price Target Raised to $101 - GuruFocus
Monster Beverage (NASDAQ:MNST) Price Target Raised to $101.00 - MarketBeat
Monster Beverage Beats Q2 Earnings on Broad-Based Sales Growth - Yahoo Finance
MNST Maintained by Evercore ISI Group -- Price Target Raised to $105 - GuruFocus
Monster Beverage (NASDAQ:MNST) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Evercore Issues Positive Forecast for Monster Beverage (NASDAQ:MNST) Stock Price - MarketBeat
Monster Beverage Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Monster Beverage Corp 2026: Revenue $2.54B, EPS $0.59— 10-Q Summary - TradingView
Monster Beverage Corporation (NASDAQ:MNST) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MNST Price History for Monster Beverage Corp Stock - Barchart.com
Monster Beverage Corp (MNST) (Q2 2026) Earnings Call Highlights: Record Sales and Global ... By GuruFocus - Investing.com Canada
Monster Beverage Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Monster Beverage tops Q2 2026 forecasts as sales hit record - Investing.com
Monster Beverage Sees Sales Jump on International Growth - Bloomberg.com
Is Monster Beverage Corp (MNST) Overvalued After Q2 Earnings Bea - GuruFocus
MONSTER BEVERAGE ($MNST) Releases Q2 2026 Earnings - Quiver Quantitative
Monster Beverage Sales Rise on International Growth - WSJ
Monster Beverage Corp (MNST) Q2 2026 Earnings - 24/7 Wall St.
MONSTER BEVERAGE CORP : RBC RAISES TARGET PRICE TO $100 FROM $97 - Bitget
Monster Beverage: Q2 Earnings Snapshot - Barchart.com
Monster Beverage earnings in focus as growth faces valuation test By Investing.com - Investing.com Canada
Monster Beverage Reports 2026 Second Quarter Financial Results - marketscreener.com
몬스터 베버리지 (MNST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.55%
자본화:
|
볼륨(24시간):